Home
/
Bionano Genomics, Inc.
/
Financials
/
Quarterly
Bionano Genomics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Bionano Genomics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$7.37M
Nov 13, 2025
Q2
2025
Jun 30, 2025
$6.73M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$6.46M
May 14, 2025
Q3
2025
Sep 30, 2024
$6.07M
Nov 13, 2025
Q2
2025
Jun 30, 2024
$7.77M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$8.77M
May 14, 2025
Q3
2024
Sep 30, 2023
$9.32M
Nov 14, 2024
Q2
2024
Jun 30, 2023
$8.66M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$7.42M
May 8, 2024
Q3
2023
Sep 30, 2022
$7.22M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$6.67M
Aug 9, 2023
Q1
2023
Mar 31, 2022
$5.70M
May 9, 2023
Q3
2022
Sep 30, 2021
$4.66M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$3.86M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$3.17M
May 5, 2022
Q3
2021
Sep 30, 2020
$2.20M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$1.18M
Aug 4, 2021
Q1
2021
Mar 31, 2020
$1.14M
May 13, 2021
Q3
2020
Sep 30, 2019
$3.31M
Nov 13, 2020
Q2
2020
Jun 30, 2019
$2.18M
Aug 13, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.50M)
Nov 13, 2025
Q3
2025
Jun 30, 2025
($6.86M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($6.86M)
Aug 14, 2025
Q2
2025
Mar 31, 2025
($3.10M)
Aug 14, 2025
Q3
2025
Mar 31, 2025
($3.10M)
Nov 13, 2025
Q1
2025
Mar 31, 2025
($3.10M)
May 14, 2025
Q3
2025
Sep 30, 2024
($44.25M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($16.22M)
Aug 14, 2025
Q3
2025
Jun 30, 2024
($16.22M)
Nov 13, 2025
Q3
2025
Mar 31, 2024
($31.42M)
Nov 13, 2025
Q1
2025
Mar 31, 2024
($31.42M)
May 14, 2025
Q2
2025
Mar 31, 2024
($31.42M)
Aug 14, 2025
Q3
2024
Sep 30, 2023
($112.57M)
Nov 14, 2024
Q3
2024
Jun 30, 2023
($38.91M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($38.91M)
Aug 7, 2024
Q3
2024
Mar 31, 2023
($37.12M)
Nov 14, 2024
Q1
2024
Mar 31, 2023
($37.12M)
May 8, 2024
Q2
2024
Mar 31, 2023
($37.12M)
Aug 7, 2024
Q3
2023
Sep 30, 2022
($31.81M)
Nov 8, 2023
Q3
2023
Jun 30, 2022
($32.16M)
Nov 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.54M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($7.80M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($8.47M)
May 14, 2025
Q3
2025
Sep 30, 2024
($43.90M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($17.02M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($31.12M)
May 14, 2025
Q3
2024
Sep 30, 2023
($113.21M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($39.24M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($37.84M)
May 8, 2024
Q3
2023
Sep 30, 2022
($32.15M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($32.08M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($29.94M)
May 9, 2023
Q3
2022
Sep 30, 2021
($20.68M)
Nov 3, 2022
Q2
2022
Jun 30, 2021
($16.48M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($11.16M)
May 5, 2022
Q3
2021
Sep 30, 2020
($10.23M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($7.44M)
Aug 4, 2021
Q1
2021
Mar 31, 2020
($9.76M)
May 13, 2021
Q3
2020
Sep 30, 2019
($5.69M)
Nov 13, 2020
Q2
2020
Jun 30, 2019
($6.84M)
Aug 13, 2020